![](/img/cover-not-exists.png)
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting
Håkan Norell, Yi Zhang, James McCracken, Telma Martins da Palma, Aaron Lesher, Yueying Liu, Jeffrey J. Roszkowski, Anquanette Temple, Glenda G. Callender, Timothy Clay, Rimas Orentas, José Guevara-PatVolume:
59
Language:
english
Pages:
12
DOI:
10.1007/s00262-009-0810-8
Date:
June, 2010
File:
PDF, 471 KB
english, 2010